JARRA GREEN-CALDERON: Open Payments
NPI 1659516615 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,129 in 59 payments from 13 companies in 2025. Trend: 2023 $3,504 · 2024 $2,137 · 2025 $4,129
Travel & lodging: $2,171Food & beverage: $1,916Education: $43
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company | 14 | $2,372 |
| Tandem Diabetes Care, Inc. | 5 | $377 |
| Dexcom, Inc. | 10 | $217 |
| Novo Nordisk Inc | 7 | $211 |
| Corcept Therapeutics | 8 | $160 |
| AstraZeneca Pharmaceuticals LP | 3 | $155 |
| CeQur Corporation | 1 | $153 |
| Neurocrine BioSciences, Inc. | 1 | $134 |
| Madrigal Pharmaceuticals | 1 | $132 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $74 |
Products named: t:slim X2 Insulin Pump with Control-IQ, Korlym, FARXIGA, CeQur Simplicity, Ozempic, CRENESSITY, REZDIFFRA, DEXCOM G7 GSS (161).
Industry payments across TX — which companies pay providers there.
